ACHV (Achieve Life Sciences Inc) צמיחת רווחים בשנה הנוכחית

Year-over-year EPS growth rates on this GURU.Markets chart capture yield dynamics, where the value -16.50 records this metric. Patent protection for Cytisinicline and FDA trials create a formidable barrier to entry for competitors. Achieve Life Sciences (ACHV) relies on future sales of its innovative smoking cessation treatment, while strong clinical data for Cytisinicline promise a stable cash generator.
פילוחי מדדים פיננסיים ומדדי שוק עבור Achieve Life Sciences Inc (ACHV)

The development of an innovative drug for nicotine addiction makes Achieve Life Sciences (ACHV) dependent on capital expenditures, which is reflected in its net income dynamics. This YoY net income per share growth rate measures the annual growth pace of earnings per share, allowing investors to assess the issuer's actual financial resilience to market shocks through the analysis of the YoY net income per share growth rate.